Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Lung Cancer

  Free Subscription


Articles published in J Thorac Cardiovasc Surg

Retrieve available abstracts of 126 articles:
HTML format
Text format



Single Articles


    September 2019
  1. TAYLOR M, Okereke I
    Commentary: Is radiation needed after resecting an early-stage small cell lung cancer?
    J Thorac Cardiovasc Surg. 2019 Sep 20. pii: S0022-5223(19)31888.
    PubMed     Text format    


  2. RAMAN V, Jawitz OK, Yang CJ, Voigt SL, et al
    Outcomes of surgery versus chemoradiotherapy in patients with clinical or pathologic stage N3 non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Sep 9. pii: S0022-5223(19)31760.
    PubMed     Text format     Abstract available


    August 2019
  3. JIANG L, Huang W, Liu J, Harris K, et al
    Endosonography with lymph node sampling for restaging the mediastinum in lung cancer: A systematic review and pooled data analysis.
    J Thorac Cardiovasc Surg. 2019 Aug 28. pii: S0022-5223(19)31649.
    PubMed     Text format     Abstract available


  4. YAMAMICHI T, Shimada Y, Masuno R, Ohira T, et al
    Association between F-18 fluorodeoxyglucose uptake of noncancerous lung area and acute exacerbation of interstitial pneumonia in patients with lung cancer after resection.
    J Thorac Cardiovasc Surg. 2019 Aug 28. pii: S0022-5223(19)31659.
    PubMed     Text format     Abstract available


  5. PANI E, Kennedy G, Zheng X, Ukert B, et al
    Factors associated with nodal metastasis in 2-centimeter or less non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Aug 25. pii: S0022-5223(19)31643.
    PubMed     Text format     Abstract available


    July 2019
  6. DONINGTON JS, Martin LW
    Commentary: The need to RIOT (return to intended oncologic treatment) after lung cancer surgery.
    J Thorac Cardiovasc Surg. 2019;158:287-288.
    PubMed     Text format    


    May 2019
  7. LUI NS
    Commentary: Should lung cancer screening guidelines go up in smoke?
    J Thorac Cardiovasc Surg. 2019 May 31. pii: S0022-5223(19)31140.
    PubMed     Text format    


  8. GROTH SS, Ripley RT, Carrott P, Burt BM, et al
    Commentary: Usurping the king: A step toward planning a biological checkmate on non-small cell lung carcinoma.
    J Thorac Cardiovasc Surg. 2019 May 30. pii: S0022-5223(19)31150.
    PubMed     Text format    


  9. KOZOWER BD
    Commentary: Invasive mediastinal staging for patients with lung cancer-We need to do better!
    J Thorac Cardiovasc Surg. 2019 May 24. pii: S0022-5223(19)31112.
    PubMed     Text format    


  10. FARJAH F, Silvestri GA, Wood DE
    Commentary: Invasive mediastinal staging for lung cancer-Quality gap, evidence gap, both?
    J Thorac Cardiovasc Surg. 2019 May 24. pii: S0022-5223(19)31113.
    PubMed     Text format    


  11. BRAVO-INIGUEZ CE, Fox SW, De Leon LE, Tarascio JN, et al
    Cumulative nonsmoking risk factors increase the probability of developing lung cancer.
    J Thorac Cardiovasc Surg. 2019 May 18. pii: S0022-5223(19)31038.
    PubMed     Text format     Abstract available


  12. MITCHELL KG, Parra ER, Nelson DB, Zhang J, et al
    Tumor cellular proliferation is associated with enhanced immune checkpoint expression in stage I non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 May 17. pii: S0022-5223(19)31015.
    PubMed     Text format     Abstract available


  13. LUI NS
    Commentary: Pleomorphic carcinoma: An aggressive type of non-small cell lung cancer that should be treated like the others.
    J Thorac Cardiovasc Surg. 2019 May 16. pii: S0022-5223(19)31004.
    PubMed     Text format    


  14. NELSON DB, Tayob N, Nguyen QN, Erasmus J, et al
    Local failure after stereotactic body radiation therapy or wedge resection for colorectal pulmonary metastases.
    J Thorac Cardiovasc Surg. 2019 May 11. pii: S0022-5223(19)30972.
    PubMed     Text format     Abstract available


  15. OSAROGIAGBON RU, Lee YS, Faris NR, Ray MA, et al
    Invasive mediastinal staging for resected non-small cell lung cancer in a population-based cohort.
    J Thorac Cardiovasc Surg. 2019 May 2. pii: S0022-5223(19)30968.
    PubMed     Text format     Abstract available


    April 2019
  16. LANUTI M
    Commentary: Cautious optimism for induction immunotherapy in resectable lung cancer.
    J Thorac Cardiovasc Surg. 2019 Apr 24. pii: S0022-5223(19)30926.
    PubMed     Text format    


  17. ALTORKI N, Lee B
    Commentary: Lobectomy or sublobar resection for early lung cancer: One small step for surgeons, one giant step for patients.
    J Thorac Cardiovasc Surg. 2019 Apr 24. pii: S0022-5223(19)30903.
    PubMed     Text format    


  18. HENDRIKSEN BS, Hollenbeak CS, Reed MF, Taylor MD, et al
    Perioperative chemotherapy is not associated with improved survival in stage I pleomorphic lung cancer.
    J Thorac Cardiovasc Surg. 2019 Apr 17. pii: S0022-5223(19)30824.
    PubMed     Text format     Abstract available


    March 2019
  19. MOORE CB, Cox ML, Mulvihill MS, Klapper J, et al
    Challenging 30-day mortality as a site-specific quality metric in non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Mar 28. pii: S0022-5223(19)30702.
    PubMed     Text format     Abstract available


  20. NELSON DB, Mehran RJ, Mitchell KG, Correa AM, et al
    Enhanced recovery after thoracic surgery is associated with improved adjuvant chemotherapy completion for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Mar 21. pii: S0022-5223(19)30677.
    PubMed     Text format     Abstract available


  21. SUBRAMANIAN M, Liu J, Greenberg C, Schumacher J, et al
    Imaging Surveillance for Surgically Resected Stage I Non-Small Cell Lung Cancer: Is More Always Better?
    J Thorac Cardiovasc Surg. 2019;157:1205-1217.
    PubMed     Text format     Abstract available


  22. ODELL DD, Feinglass J, Engelhardt K, Papastefan S, et al
    Evaluation of adherence to the Commission on Cancer lung cancer quality measures.
    J Thorac Cardiovasc Surg. 2019;157:1219-1235.
    PubMed     Text format     Abstract available


    February 2019
  23. STILES BM, Mao J, Harrison S, Lee B, et al
    Extent of lymphadenectomy is associated with oncological efficacy of sublobar resection for lung cancer </=2 cm.
    J Thorac Cardiovasc Surg. 2019 Feb 28. pii: S0022-5223(19)30533.
    PubMed     Text format     Abstract available


  24. VAN BERKEL V
    Commentary: Still not enough data yet-Sublobar resection versus lobectomy for lung cancer.
    J Thorac Cardiovasc Surg. 2019 Feb 19. pii: S0022-5223(19)30461.
    PubMed     Text format    


  25. GRAVIER FE, Bonnevie T, Boujibar F, Medrinal C, et al
    Effect of prehabilitation on ventilatory efficiency in non-small cell lung cancer patients: A cohort study.
    J Thorac Cardiovasc Surg. 2019 Feb 19. pii: S0022-5223(19)30448.
    PubMed     Text format     Abstract available


  26. LATIF MJ, Tan KS, Molena D, Huang J, et al
    Perioperative blood transfusion has a dose-dependent relationship with disease recurrence and survival in patients with non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Feb 12. pii: S0022-5223(19)30351.
    PubMed     Text format     Abstract available


    January 2019
  27. SALTER KD, Burt BM
    Commentary: Postoperative blood transplantation for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Jan 25. pii: S0022-5223(19)30259.
    PubMed     Text format    


  28. GUCKENBERGER M, Aerts JG, Van Schil P, Weder W, et al
    The American Society of Clinical Oncology-endorsed American Society for Radiation Oncology Evidence-Based Guideline of stereotactic body radiotherapy for early-stage non-small cell lung cancer: An expert opinion.
    J Thorac Cardiovasc Surg. 2019;157:358-361.
    PubMed     Text format    


  29. GROTH SS, Ripley RT, Burt BM
    A thinner peel to peel: Pleural thickness is prognostic in mesothelioma.
    J Thorac Cardiovasc Surg. 2019;157:414-415.
    PubMed     Text format    


  30. SEMENKOVICH TR, Puri V
    Surgery versus stereotactic body radiation therapy: Definitive evidence is still elusive.
    J Thorac Cardiovasc Surg. 2019;157:374-375.
    PubMed     Text format    


  31. OKADA M, Miyata Y, Takamochi K, Tsutani Y, et al
    Prospective feasibility study of sealing pulmonary vessels with energy in lung surgery.
    J Thorac Cardiovasc Surg. 2019;157:388-395.
    PubMed     Text format     Abstract available


    December 2018
  32. SAMSON P
    It's time to check our bias: Ensuring health equity for patients with lung cancer.
    J Thorac Cardiovasc Surg. 2018 Dec 27. pii: S0022-5223(18)33499.
    PubMed     Text format    


  33. HSIN MK, Ho JC
    It is not as bad as they say: The risks of surgery in screening-detected lung cancer are overstated.
    J Thorac Cardiovasc Surg. 2018 Dec 25. pii: S0022-5223(18)33482.
    PubMed     Text format    


  34. YANG CJ, Yendamuri S, Mayne NR, Battoo A, et al
    The role of thoracoscopic pneumonectomy in the management of non-small cell lung cancer: A multicenter study.
    J Thorac Cardiovasc Surg. 2018 Dec 18. pii: S0022-5223(18)33419.
    PubMed     Text format     Abstract available


  35. BOTT MJ, Yang SC, Park BJ, Adusumilli PS, et al
    Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Dec 13. pii: S0022-5223(18)33277.
    PubMed     Text format     Abstract available


  36. WOLF A, Alpert N, Tran BV, Liu B, et al
    Persistence of racial disparities in early-stage lung cancer treatment.
    J Thorac Cardiovasc Surg. 2018 Dec 11. pii: S0022-5223(18)33258.
    PubMed     Text format     Abstract available


  37. FERRARI-LIGHT D, Cerfolio RJ
    Are we really operating on advanced stage non-small cell lung cancer?
    J Thorac Cardiovasc Surg. 2018 Dec 4. pii: S0022-5223(18)33219.
    PubMed     Text format    


  38. OKAMURA A, Watanabe M, Hayami M, Mine S, et al
    Esophagectomy via upper partial sternotomy for esophageal cancer after previous right pneumonectomy: A case report.
    J Thorac Cardiovasc Surg. 2018;156:e217-e220.
    PubMed     Text format    


    November 2018
  39. FERNANDEZ FG, Kosinski AS, Tong BC, Furnary AP, et al
    Lack of correlation between short- and long-term performance after lung cancer surgery.
    J Thorac Cardiovasc Surg. 2018 Nov 27. pii: S0022-5223(18)33141.
    PubMed     Text format     Abstract available


  40. NELSON DB, Tayob N, Mitchell KG, Correa AM, et al
    Surgical margins and risk of local recurrence after wedge resection of colorectal pulmonary metastases.
    J Thorac Cardiovasc Surg. 2018 Nov 26. pii: S0022-5223(18)33149.
    PubMed     Text format     Abstract available


  41. DAVID EA, Andersen SW, Beckett LA, Melnikow J, et al
    Survival benefits associated with surgery for advanced non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Nov 14. pii: S0022-5223(18)32941.
    PubMed     Text format     Abstract available


  42. DONINGTON JS
    Keeping surgery relevant in oligometastatic non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Nov 8. pii: S0022-5223(18)32903.
    PubMed     Text format    


  43. HARRISON MS, Frye CC, Puri V
    Health metrics in lung cancer care: Measure, improve, repeat.
    J Thorac Cardiovasc Surg. 2018 Nov 2. pii: S0022-5223(18)32879.
    PubMed     Text format    


    October 2018
  44. KORST RJ, Santana-Joseph S
    Quality metrics for lung cancer care: Far from perfect, but close to reality.
    J Thorac Cardiovasc Surg. 2018 Oct 28. pii: S0022-5223(18)32858.
    PubMed     Text format    


  45. SUBRAMANIAN MP, Puri V
    Surveillance and the second primary lung cancer: Enhancing our understanding beyond Martini and Melamed.
    J Thorac Cardiovasc Surg. 2018 Oct 26. pii: S0022-5223(18)32833.
    PubMed     Text format    


  46. FARJAH F, Kessler L
    Rightsizing lung cancer surveillance.
    J Thorac Cardiovasc Surg. 2018 Oct 22. pii: S0022-5223(18)32803.
    PubMed     Text format    


  47. ZHANG Y, Chen H
    Neoadjuvant or adjuvant chemotherapy for non-small-cell lung cancer: Does the timing matter?
    J Thorac Cardiovasc Surg. 2018 Oct 12. pii: S0022-5223(18)32632.
    PubMed     Text format    


  48. BRUNELLI A
    The timing of chemotherapy in multimodality treatment of locally advanced lung cancer: One size does not fit all.
    J Thorac Cardiovasc Surg. 2018 Oct 10. pii: S0022-5223(18)32609.
    PubMed     Text format    


  49. BRANDT WS, Yan W, Zhou J, Tan KS, et al
    Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer: A propensity-matched analysis.
    J Thorac Cardiovasc Surg. 2018 Oct 10. pii: S0022-5223(18)32606.
    PubMed     Text format     Abstract available


  50. WANG Y, Yeung JC, Hanna WC, Allison F, et al
    Metachronous or synchronous primary lung cancer in the era of computed tomography surveillance.
    J Thorac Cardiovasc Surg. 2018 Oct 6. pii: S0022-5223(18)32556.
    PubMed     Text format     Abstract available


    September 2018
  51. CAO C, Wang D, Chung C, Tian D, et al
    A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Sep 15. pii: S0022-5223(18)32347.
    PubMed     Text format     Abstract available


  52. ENGELHARDT KE, Feinglass JM, DeCamp MM, Bilimoria KY, et al
    Treatment trends in early-stage lung cancer in the United States, 2004 to 2013: A time-trend analysis of the National Cancer Data Base.
    J Thorac Cardiovasc Surg. 2018;156:1233-1246.
    PubMed     Text format     Abstract available


    August 2018
  53. FERNANDEZ-RODRIGUEZ L, Torres I, Romera D, Galera R, et al
    Prediction of postoperative lung function after major lung resection for lung cancer using volumetric computed tomography.
    J Thorac Cardiovasc Surg. 2018 Aug 2. pii: S0022-5223(18)32018.
    PubMed     Text format     Abstract available


    July 2018
  54. LIN J, Fernandez F
    Indications for invasive mediastinal staging for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Jul 21. pii: S0022-5223(18)31872.
    PubMed     Text format    


  55. HOANG CD
    Adjuvant chemotherapy in stage I lung cancer: Is more better?
    J Thorac Cardiovasc Surg. 2018 Jul 19. pii: S0022-5223(18)31821.
    PubMed     Text format    


  56. WANG S, Xu J, Wang R, Qian F, et al
    Adjuvant chemotherapy may improve prognosis after resection of stage I lung cancer with lymphovascular invasion.
    J Thorac Cardiovasc Surg. 2018 Jul 18. pii: S0022-5223(18)31779.
    PubMed     Text format     Abstract available


  57. UPHAM TC, Onaitis MW
    Video-assisted thoracoscopic surgery versus robot-assisted thoracoscopic surgery versus thoracotomy for early-stage lung cancer.
    J Thorac Cardiovasc Surg. 2018;156:365-368.
    PubMed     Text format    


    June 2018
  58. SCHRUMP DS, Hong JA
    Analysis of circulating tumor DNA: The next paradigm shift in detection and treatment of lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:2632-2633.
    PubMed     Text format    


    May 2018
  59. HATTORI A, Suzuki K
    New era defining a novel clinical T staging in non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:2179-2180.
    PubMed     Text format    


    April 2018
  60. SWANSON SJ
    Good vibrations-better care for lung cancer patients.
    J Thorac Cardiovasc Surg. 2018 Apr 13. pii: S0022-5223(18)30994.
    PubMed     Text format    


  61. BRUNELLI A
    It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible.
    J Thorac Cardiovasc Surg. 2018 Apr 12. pii: S0022-5223(18)30962.
    PubMed     Text format    


  62. OKIROR L, Harling L, Toufektzian L, King J, et al
    Prognostic factors including lymphovascular invasion on survival for resected non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Apr 12. pii: S0022-5223(18)30935.
    PubMed     Text format     Abstract available


  63. CAO J, Xu J, He Z, Yuan P, et al
    Prognostic impact of lymphadenectomy on outcomes of sublobar resection for stage IA non-small cell lung cancer </=2 cm.
    J Thorac Cardiovasc Surg. 2018 Apr 6. pii: S0022-5223(18)30905.
    PubMed     Text format     Abstract available


  64. YENDAMURI S, Dhillon SS, Groman A, Dy G, et al
    Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection.
    J Thorac Cardiovasc Surg. 2018 Apr 4. pii: S0022-5223(18)30895.
    PubMed     Text format     Abstract available


  65. MAO Q, Xia W, Dong G, Chen S, et al
    A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery.
    J Thorac Cardiovasc Surg. 2018;155:1784-1792.
    PubMed     Text format     Abstract available


    March 2018
  66. KRUSER TJ, Mohindra N, DeCamp MM
    One size does not fit all: Nuances in postoperative N2 non-small cell lung cancer management.
    J Thorac Cardiovasc Surg. 2018 Mar 29. pii: S0022-5223(18)30865.
    PubMed     Text format    


  67. ISBELL JM, Jones DR, Li BT
    Circulating tumor DNA: A promising biomarker to guide postoperative treatment and surveillance of non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Mar 13. pii: S0022-5223(18)30707.
    PubMed     Text format    


  68. AJMANI GS, Wang CH, Kim KW, Howington JA, et al
    Surgical quality of wedge resection affects overall survival in patients with early stage non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Mar 13. pii: S0022-5223(18)30776.
    PubMed     Text format     Abstract available


  69. CAMERON RB
    Adherence to lung cancer surgical quality standards is critical for the survival of both our patients and our specialty.
    J Thorac Cardiovasc Surg. 2018 Mar 7. pii: S0022-5223(18)30612.
    PubMed     Text format    


  70. SU K, Gao S, Ying J, Zou S, et al
    Sequencing a super multiple synchronous lung cancer reveals a novel variant in driver gene ARID1B.
    J Thorac Cardiovasc Surg. 2018 Mar 6. pii: S0022-5223(18)30059.
    PubMed     Text format    


  71. ROCCO G
    Every breath you take: The value of the electronic nose (e-nose) technology in the early detection of lung cancer.
    J Thorac Cardiovasc Surg. 2018 Mar 2. pii: S0022-5223(18)30604.
    PubMed     Text format    


  72. BRUNELLI A
    Short-term outcomes do not capture the real value of lung cancer surgery.
    J Thorac Cardiovasc Surg. 2018;155:1311-1312.
    PubMed     Text format    


  73. MEHRAN RJ, Martin LW, Roth JA
    Comparison of outcomes between muscle-sparing thoracotomy and video-assisted thoracic surgery in patients with cT1 N0 M0 lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:1307.
    PubMed     Text format    


    February 2018
  74. SEPESI B, Ye Y, Mitchell KG, Zhang L, et al
    Genetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patients.
    J Thorac Cardiovasc Surg. 2018 Feb 15. pii: S0022-5223(18)30372.
    PubMed     Text format     Abstract available


  75. CHENG X, Zheng D, Li Y, Li H, et al
    Tumor histology predicts mediastinal nodal status and may be used to guide limited lymphadenectomy in patients with clinical stage I non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Feb 13. pii: S0022-5223(18)30362.
    PubMed     Text format     Abstract available


  76. MUNOZ-LARGACHA JA, Steiling KA, Kathuria H, Charlot M, et al
    Initial surgical experience following implementation of lung cancer screening at an urban safety net hospital.
    J Thorac Cardiovasc Surg. 2018 Feb 9. pii: S0022-5223(18)30308.
    PubMed     Text format     Abstract available


  77. THORNBLADE LW, Wood DE, Mulligan MS, Farivar AS, et al
    Variability in invasive mediastinal staging for lung cancer: A multicenter regional study.
    J Thorac Cardiovasc Surg. 2018 Feb 9. pii: S0022-5223(18)30311.
    PubMed     Text format     Abstract available


  78. RUSTHOVEN CG, Jones BL, Kavanagh BD
    Medical operability and inoperability drive survival in retrospective analyses comparing surgery and SBRT for early-stage lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:810-811.
    PubMed     Text format    


    January 2018
  79. AHMAD U, Machuzak M
    Electric shock therapy for lung cancer: Taking palliation to the next level.
    J Thorac Cardiovasc Surg. 2018 Jan 31. pii: S0022-5223(18)30245.
    PubMed     Text format    


  80. MOGHANAKI D, Simone CB 2nd, Rimner A, Karas TZ, et al
    The value of collaboration between thoracic surgeons and radiation oncologists while awaiting evidence in operable stage i non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:429-431.
    PubMed     Text format    


    December 2017
  81. NOMORI H, Shiraishi A, Cong Y, Shoji K, et al
    Impact of induction chemoradiotherapy on pulmonary function after lobectomy for lung cancer.
    J Thorac Cardiovasc Surg. 2017 Dec 26. pii: S0022-5223(17)33059.
    PubMed     Text format     Abstract available


  82. RUSCH VW, Chaft J, Hellmann M
    KEYNOTE-024: Unlocking a pathway to lung cancer cure?
    J Thorac Cardiovasc Surg. 2017 Dec 23. pii: S0022-5223(17)33029.
    PubMed     Text format    


  83. ROGERS LJ, Bleetman D, Messenger DE, Joshi NA, et al
    The impact of enhanced recovery after surgery (ERAS) protocol compliance on morbidity from resection for primary lung cancer.
    J Thorac Cardiovasc Surg. 2017 Dec 19. pii: S0022-5223(17)32855.
    PubMed     Text format     Abstract available


  84. DRAKE JA, Sullivan JL, Weksler B
    Adjuvant chemotherapy improves survival in patients with completely resected T3N0 non-small cell lung cancer invading the chest wall.
    J Thorac Cardiovasc Surg. 2017 Dec 19. pii: S0022-5223(17)32857.
    PubMed     Text format     Abstract available


  85. DIGESU CS, Hachey KJ, Gilmore DM, Khullar OV, et al
    Long-term outcomes after near-infrared sentinel lymph node mapping in non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Dec 13. pii: S0022-5223(17)32505.
    PubMed     Text format     Abstract available


  86. BRUNELLI A
    Time of modeling survival of patients with stage III-N2 non-small cell lung cancer: Before or after surgery makes a difference.
    J Thorac Cardiovasc Surg. 2017 Dec 12. pii: S0022-5223(17)32837.
    PubMed     Text format    


    November 2017
  87. GELLER AD, Zheng H, Mathisen DJ, Wright CD, et al
    Relative incremental costs of complications of lobectomy for stage I non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 20. pii: S0022-5223(17)32702.
    PubMed     Text format     Abstract available


  88. NEGRAO MV, Quek K, Zhang J, Sepesi B, et al
    TRACERx: Tracking tumor evolution to impact the course of lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 16. pii: S0022-5223(17)32689.
    PubMed     Text format    


  89. FERNANDEZ FG, Kosinski AS, Furnary AP, Onaitis M, et al
    Differential effects of operative complications on survival after surgery for primary lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 13. pii: S0022-5223(17)32503.
    PubMed     Text format     Abstract available


  90. WEKSLER B
    Resection of pleural implants in patients with lung cancer should remain the exception rather than the rule.
    J Thorac Cardiovasc Surg. 2017 Nov 8. pii: S0022-5223(17)32459.
    PubMed     Text format    


  91. LIN J
    Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow?
    J Thorac Cardiovasc Surg. 2017 Nov 6. pii: S0022-5223(17)32471.
    PubMed     Text format    


  92. CHENG X, Chen H
    Commentary on the impacts of postoperative complications on survival after lung cancer surgery.
    J Thorac Cardiovasc Surg. 2017 Nov 6. pii: S0022-5223(17)32470.
    PubMed     Text format    


  93. ZHENG D, Ye T, Hu H, Zhang Y, et al
    Upfront surgery as first-line therapy in selected patients with stage IIIA non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 3. pii: S0022-5223(17)32409.
    PubMed     Text format     Abstract available


  94. LIU M, Wigle D, Wampfler JA, Dai J, et al
    T category of non-small cell lung cancer invading the fissure to the adjacent lobe.
    J Thorac Cardiovasc Surg. 2017;154:1777-1783.
    PubMed     Text format     Abstract available


  95. LANUTI M
    Risk stratification for distant recurrence of resected early stage non-small cell lung cancer is under construction.
    J Thorac Cardiovasc Surg. 2017 Nov 1. pii: S0022-5223(17)32392.
    PubMed     Text format    


    October 2017
  96. MOLENA D
    Shining light on sentinel node assessment for lung cancer: Quality is superior to quantity.
    J Thorac Cardiovasc Surg. 2017 Oct 20. pii: S0022-5223(17)32331.
    PubMed     Text format    


    September 2017
  97. DETTERBECK FC
    The eighth edition TNM stage classification for lung cancer: What does it mean on main street?
    J Thorac Cardiovasc Surg. 2017 Sep 28. pii: S0022-5223(17)32136.
    PubMed     Text format    


  98. ZHANG Z, Mostofian F, Ivanovic J, Gilbert S, et al
    All grades of severity of postoperative adverse events are associated with prolonged length of stay after lung cancer resection.
    J Thorac Cardiovasc Surg. 2017 Sep 28. pii: S0022-5223(17)32135.
    PubMed     Text format     Abstract available


  99. TURNA A, Melek H, Kara HV, Kilic B, et al
    Validity of the updated European Society of Thoracic Surgeons staging guideline in lung cancer patients.
    J Thorac Cardiovasc Surg. 2017 Sep 27. pii: S0022-5223(17)32131.
    PubMed     Text format     Abstract available


  100. CERFOLIO RJ, Ghanim AF, Dylewski M, Veronesi G, et al
    The long-term survival of robotic lobectomy for non-small cell lung cancer: A multi-institutional study.
    J Thorac Cardiovasc Surg. 2017 Sep 18. pii: S0022-5223(17)31919.
    PubMed     Text format     Abstract available


  101. GILBERT CR, Ely R, Fathi JT, Louie BE, et al
    The economic impact of a nurse practitioner-directed lung cancer screening, incidental pulmonary nodule, and tobacco-cessation clinic.
    J Thorac Cardiovasc Surg. 2017 Sep 13. pii: S0022-5223(17)31890.
    PubMed     Text format     Abstract available


  102. SEDER CW
    Lung cancer screening is here to stay, but does it pay?
    J Thorac Cardiovasc Surg. 2017 Sep 12. pii: S0022-5223(17)31887.
    PubMed     Text format    


  103. ANTONOFF MB
    Multifocal lung cancer within ground glass lesions: Are favorable outcomes consequent to surgical resection or inherent to the disease?
    J Thorac Cardiovasc Surg. 2017 Sep 8. pii: S0022-5223(17)31866.
    PubMed     Text format    


  104. TONG BC
    Lung cancer screening: No more excuses.
    J Thorac Cardiovasc Surg. 2017 Sep 5. pii: S0022-5223(17)31853.
    PubMed     Text format    


  105. LIU C, Liu L
    Reappraise the advanced technique for tumor localization and sentinel lymph node assessment in clinical early-stage non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017;154:1134.
    PubMed     Text format    


  106. DIGESU CS, Colson YL
    A "green" light for staging in early lung cancer.
    J Thorac Cardiovasc Surg. 2017;154:1134-1136.
    PubMed     Text format    


  107. FLORES RM
    Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery.
    J Thorac Cardiovasc Surg. 2017 Sep 1. pii: S0022-5223(17)31820.
    PubMed     Text format    


  108. KIDANE B
    Stereotactic body radiation therapy versus video-assisted thoracoscopic surgery in stage I lung cancer: Honesty in the face of uncertainty.
    J Thorac Cardiovasc Surg. 2017 Sep 1. pii: S0022-5223(17)31821.
    PubMed     Text format    


  109. HATTORI A, Matsunaga T, Takamochi K, Oh S, et al
    Prognostic impact of a ground glass opacity component in the clinical T classification of non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Sep 1. pii: S0022-5223(17)31798.
    PubMed     Text format     Abstract available


  110. BURT BM
    Programmed death ligand 1-associated antitumor immunity in early-stage non-small cell lung cancer: Expression of major histocompatibility complex I as a prerequisite.
    J Thorac Cardiovasc Surg. 2017 Sep 1. pii: S0022-5223(17)31823.
    PubMed     Text format    


    August 2017
  111. CORNWELL LD, Echeverria AE, Samuelian J, Mayor J, et al
    Video-assisted thoracoscopic lobectomy is associated with greater recurrence-free survival than stereotactic body radiotherapy for clinical stage I lung cancer.
    J Thorac Cardiovasc Surg. 2017 Aug 16. pii: S0022-5223(17)31718.
    PubMed     Text format     Abstract available


    July 2017
  112. FERNANDEZ FG
    What are the gaps in quality measurement for lung cancer surgery?
    J Thorac Cardiovasc Surg. 2017 Jul 1. pii: S0022-5223(17)31367.
    PubMed     Text format    


    June 2017
  113. SCHAHEEN LW, D'Cunha J
    The slippery slope of nonoperative therapy in early-stage lung cancer.
    J Thorac Cardiovasc Surg. 2017 Jun 10. pii: S0022-5223(17)31178.
    PubMed     Text format    


  114. BRANDT WS, Isbell JM, Jones DR
    Defining quality in the surgical care of lung cancer patients.
    J Thorac Cardiovasc Surg. 2017 Jun 9. pii: S0022-5223(17)31171.
    PubMed     Text format    


    May 2017
  115. CHEN K, Zhang J, Guan T, Yang F, et al
    Comparison of plasma to tissue DNA mutations in surgical patients with non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 May 24. pii: S0022-5223(17)31084.
    PubMed     Text format     Abstract available


  116. ZHAO Y, Li G, Zhang Y, Hu H, et al
    Comparison of outcomes between muscle-sparing thoracotomy and video-assisted thoracic surgery in patients with cT1 N0 M0 lung cancer.
    J Thorac Cardiovasc Surg. 2017 May 20. pii: S0022-5223(17)31049.
    PubMed     Text format     Abstract available


  117. NGUYEN DM, Villamizar N
    "One-stop shop" tumor tattooing and sentinel lymph node mapping: A new paradigm for lung cancer therapy.
    J Thorac Cardiovasc Surg. 2017 May 17. pii: S0022-5223(17)30908.
    PubMed     Text format    


    April 2017
  118. WEKSLER B
    One in every 14 patients with early-stage lung cancer is not being treated!
    J Thorac Cardiovasc Surg. 2017 Apr 24. pii: S0022-5223(17)30850.
    PubMed     Text format    


  119. HOANG CD
    Protein-based prognostic biomarkers in lung cancer: Promise or pitfall?
    J Thorac Cardiovasc Surg. 2017 Apr 23. pii: S0022-5223(17)30851.
    PubMed     Text format    


  120. FERRARIS VA
    Interstitial lung disease and lung cancer: Decisions, precision, and tuna fish sandwiches.
    J Thorac Cardiovasc Surg. 2017 Apr 23. pii: S0022-5223(17)30848.
    PubMed     Text format    


  121. BURT BM
    Incompletely resected non-small cell lung cancer: Do we know how to handle a positive margin?
    J Thorac Cardiovasc Surg. 2017 Apr 12. pii: S0022-5223(17)30689.
    PubMed     Text format    


  122. BERRY MF
    Evidence for resection of sarcoma pulmonary metastases: More, but better?
    J Thorac Cardiovasc Surg. 2017 Apr 7. pii: S0022-5223(17)30658.
    PubMed     Text format    


  123. MCMURRY TL, Shah PM, Samson P, Robinson CG, et al
    Treatment of stage I non-small cell lung cancer: What's trending?
    J Thorac Cardiovasc Surg. 2017 Apr 5. pii: S0022-5223(17)30643.
    PubMed     Text format     Abstract available


  124. YEROKUN BA, Yang CJ, Gulack BC, Li X, et al
    A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Apr 4. pii: S0022-5223(17)30639.
    PubMed     Text format     Abstract available


  125. TSUTANI Y, Mimura T, Kai Y, Ito M, et al
    Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease.
    J Thorac Cardiovasc Surg. 2017 Apr 4. pii: S0022-5223(17)30635.
    PubMed     Text format     Abstract available


  126. SMELTZER MP, Lin CC, Kong FS, Jemal A, et al
    Survival impact of postoperative therapy modalities according to margin status in non-small cell lung cancer patients in the United States.
    J Thorac Cardiovasc Surg. 2017 Apr 4. pii: S0022-5223(17)30604.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: